Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
For Dihexa to progress in Alzheimer's research, several conditions would need to be met: Earlier intervention: Testing in cognitively normal individuals at high risk, or mild cognitive impairment, rather than established dementia Bioavailability optimization: Development of oral formulations with superior brain penetration, or better-tolerated intravenous regimens Combination approaches: Testing Dihexa alongside amyloid-targeting drugs or tau-focused therapeutics Mechanism refinement: Understanding which aspects of HGF signalling are beneficial versus which drive cancer risk concerns Patient stratification: Identifying subgroups (by genetics, biomarker status, disease stage) most likely to respond Dose optimization: The LIFT-AD trial used specific doses
These effects are mediated by downregulation of VE-cadherin, occludin, and claudin-5 and increased levels of oxidative stress in endothelial cell monolayers and co-cultured with pericytes
The peptide glycyl--histidyl--lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals
5,11 Laboratory studies have examined GHK's effects on lipid peroxidation markers and reactive oxygen species (ROS) levels across various cultured cell types
US$ 27.55
US$ 25.15
US$ 27.63
US$ 20.72
US$ 25.90
